Key result
Lifelong beta-blocker therapy reduces cardiac output by ~30% without altering arterial pressure, redistributing regional flow.
Why the study?
The study aimed to quantitatively determine organ blood flow distribution resulting from lifelong beta-adrenergic receptor blockade in normotensive and spontaneously hypertensive rats.
Answers are grounded in this paper and cite their sources.
Beta-blockade reduced CO with skeletal muscle flow redistribution in rats; leaves open whether lifelong therapy alters human hypertension or organ perfusion.
To determine quantitatively organ blood flow distribution as the result of lifelong beta-adrenergic receptor blockade, 23 and 24 normotensive Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) rats, respectively, were treated from conception with tap water (control; 10 WKY and 8 SHR), propranolol (0.5 mg/ml drinking water; 6 WKY and 8 SHR), or timolol (0.5 mg/ml drinking water; 7 WKY and 8 SHR) via placental circulation, mothers' milk, and drinking water. At 12 weeks of age all six groups were studied hemodynamically under ether anesthesia using an electromagnetic flowmeter and radioactive carbonized (15 micrometer) microspheres. Untreated SHR demonstrated normal cardiac output (CO) and CO distribution to all organs except for myocardium and testes, thereby confirming our previous work. With either propranolol or timolol treatment the course of development and maintenance of arterial pressure was no different than the pure-tap-water-fed WKY and SHR despite an approximate 30% reduction in CO. Further, with both beta-receptor antagonists CO distribution was significantly reduced to skeletal muscle (p less than 0.001), unchanged to the heart, and increased (p less than 0.05) to the remaining organs (including kidneys and brain) in both groups. Thus, as a result of lifelong beta-adrenergic receptor blockade, CO was reduced; and this was associated with a redistribution of blood flow so that flow to the kidney, brain, and splanchnic organs could be maintained at the expense of skeletal muslce perfusion.
No takes yet. Share an insight, caveat, or question.
Nishiyama et al. (2008) studied Spontaneous hypertension and normotension (rat model) (n=47). Propranolol or timolol vs. Pure tap water (control) was evaluated on Systemic hemodynamics (cardiac output and arterial pressure) and regional organ blood flow distribution (p=<0.001). Lifelong propranolol or timolol reduced cardiac output by ~30% without altering arterial pressure, decreasing skeletal muscle flow while increasing kidney and brain flow.
Synapse has enriched 10 related papers. Consider them for comparative context: